1,25-Dihydroxyvitamin D3 affects gastric cancer progression by repressing BMP3 promoter methylation.

MLA

Zhao, Ye, et al. “1,25-Dihydroxyvitamin D3 Affects Gastric Cancer Progression by Repressing BMP3 Promoter Methylation.” OncoTargets & Therapy, vol. 12, Mar. 2019, pp. 2343–53. EBSCOhost, https://doi.org/10.2147/OTT.S195642.

APA

Zhao, Y., Cai, L.-L., Wang, H.-L., Shi, X.-J., Ye, H.-M., Song, P., Huang, B.-Q., & Tzeng, C.-M. (2019). 1,25-Dihydroxyvitamin D3 affects gastric cancer progression by repressing BMP3 promoter methylation. OncoTargets & Therapy, 12, 2343–2353. https://doi.org/10.2147/OTT.S195642

Chicago

Zhao, Ye, Liang-Liang Cai, Hui-Ling Wang, Xiao-Juan Shi, Hui-Ming Ye, Ping Song, Bao-Qi Huang, and Chi-Meng Tzeng. 2019. “1,25-Dihydroxyvitamin D3 Affects Gastric Cancer Progression by Repressing BMP3 Promoter Methylation.” OncoTargets & Therapy 12 (March): 2343–53. doi:10.2147/OTT.S195642.